Matthias Evers is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as an Independent Director at IMIDomics Inc. since October 2024 and as a Board Member at Angelini Ventures since June 2023. Prior to this, Matthias held the position of Chief Business Officer at Evotec from May 2022 to October 2024, where responsibilities included collaborating in a shared R&D economy with a focus on PanOmics-driven drug discovery and iPSC-based cell therapies. Matthias's extensive career also includes a significant tenure at McKinsey & Company, where a Senior Partner role was undertaken from March 2002 to May 2022. Earlier academic work involved a PhD and Postdoctoral position at the Center for Molecular Neurobiology Hamburg from 1999 to 2002, following a degree from Ruhr University Bochum from 1994 to 1998.
This person is not in the org chart
This person is not in any teams
This person is not in any offices